Published in Ann Surg on August 01, 2014
Electronic health records in ambulatory care--a national survey of physicians. N Engl J Med (2008) 17.18
Use of electronic health records in U.S. hospitals. N Engl J Med (2009) 14.36
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg (2006) 7.18
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24
Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg (2004) 5.12
How common are electronic health records in the United States? A summary of the evidence. Health Aff (Millwood) (2006) 4.55
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery (2012) 3.87
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 3.73
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery (2007) 3.42
Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg (2007) 3.38
Options for slowing the growth of health care costs. N Engl J Med (2008) 3.24
Patient-physician connectedness and quality of primary care. Ann Intern Med (2009) 3.01
Limited English proficiency and breast and cervical cancer screening in a multiethnic population. Am J Public Health (2005) 2.89
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg (2015) 2.79
Professionalism in medicine: results of a national survey of physicians. Ann Intern Med (2007) 2.70
The role of quality improvement in strengthening health systems in developing countries. Int J Qual Health Care (2010) 2.61
Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients. Ann Surg (2005) 2.58
Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol (2002) 2.44
Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg (2004) 2.35
Preparedness of internal medicine and family practice residents for treating common conditions. JAMA (2002) 2.35
Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol (2009) 2.35
Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg (2004) 2.29
Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Ann Surg (2013) 2.26
Survival and changes in comorbidities after bariatric surgery. Ann Surg (2008) 2.19
Surgical privileging and credentialing: a report of a discussion and study group of the American Surgical Association. J Am Coll Surg (2009) 2.18
Use of national surgical quality improvement program data as a catalyst for quality improvement. J Am Coll Surg (2007) 2.18
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg (2007) 2.10
Major bile duct injuries associated with laparoscopic cholecystectomy: effect of surgical repair on quality of life. Ann Surg (2002) 2.09
Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery (2006) 2.07
Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res (2002) 2.07
Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst (2009) 1.92
A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg (2006) 1.89
Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol (2008) 1.88
A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate? J Am Coll Surg (2010) 1.83
Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment. J Gastrointest Surg (2007) 1.83
Bands and bypasses: 30-day morbidity and mortality of bariatric surgical procedures as assessed by prospective, multi-center, risk-adjusted ACS-NSQIP data. Surg Endosc (2008) 1.82
FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Oncologist (2013) 1.76
Hospital readmission after pancreaticoduodenectomy. J Gastrointest Surg (2006) 1.73
Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience. Arch Surg (2010) 1.72
Uptake of electronic prescribing in community-based practices. J Gen Intern Med (2008) 1.69
Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg (2003) 1.66
Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg (2007) 1.62
Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms: a study of 39 cases. Am J Surg Pathol (2002) 1.59
Surgical site infection prevention: the importance of operative duration and blood transfusion--results of the first American College of Surgeons-National Surgical Quality Improvement Program Best Practices Initiative. J Am Coll Surg (2008) 1.56
Natural history of pancreatitis-induced splenic vein thrombosis: a systematic review and meta-analysis of its incidence and rate of gastrointestinal bleeding. HPB (Oxford) (2011) 1.54
Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1). J Mol Cell Cardiol (2006) 1.48
Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma. J Gastrointest Surg (2008) 1.47
Robotic distal pancreatectomy: cost effective? Surgery (2010) 1.47
Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival. J Gastrointest Surg (2005) 1.46
Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg (2007) 1.45
Will physician-level measures of clinical performance be used in medical malpractice litigation? JAMA (2006) 1.45
Pancreatic cancer: progress made. Acta Oncol (2010) 1.44
Evolution of the Whipple procedure at the Massachusetts General Hospital. Surgery (2012) 1.40
Massachusetts General Physicians Organization's quality incentive program produces encouraging results. Health Aff (Millwood) (2013) 1.40
Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg (2005) 1.39
Caring for high-need, high-cost patients: what makes for a successful care management program? Issue Brief (Commonw Fund) (2014) 1.36
Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis. Ann Surg (2006) 1.36
Predicting resectability of periampullary cancer with three-dimensional computed tomography. J Gastrointest Surg (2004) 1.34
CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg (2007) 1.34
Who is using chronic acid suppression therapy and why? Am J Gastroenterol (2003) 1.34
Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management. J Gastrointest Surg (2007) 1.34
Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol (2003) 1.33
Expert panel on weight loss surgery: executive report update. Obesity (Silver Spring) (2009) 1.33
Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys (2007) 1.31
Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial. J Am Coll Surg (2009) 1.29
Depressive symptom burden as a barrier to screening for breast and cervical cancers. J Womens Health (Larchmt) (2004) 1.28
Pancreaticoduodenectomy: role of interventional radiologists in managing patients and complications. J Gastrointest Surg (2003) 1.26
A prospective, randomized study of EUS-guided celiac plexus neurolysis for pancreatic cancer: one injection or two? Gastrointest Endosc (2011) 1.25
Utility of the surgical apgar score: validation in 4119 patients. Arch Surg (2009) 1.24
Forgotten pioneers of pancreatic surgery: beyond the favorite few. Ann Surg (2008) 1.24
Correlates of use of specialty care. Pediatrics (2004) 1.24
Pancreatic acinar cell carcinoma: a multi-institutional study. J Gastrointest Surg (2009) 1.23
In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery (2007) 1.22
Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer. J Gastrointest Surg (2006) 1.22
Percutaneous management of bile duct strictures and injuries associated with laparoscopic cholecystectomy: a decade of experience. J Am Coll Surg (2004) 1.21
Annular pancreas: dramatic differences between children and adults. J Am Coll Surg (2008) 1.21
Incidence and outcome of biliary strictures after pancreaticoduodenectomy. Ann Surg (2006) 1.19
Effect of work-hour reforms on operative case volume of surgical residents. Curr Surg (2005) 1.18
Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg (2009) 1.18
Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg (2003) 1.18
Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery (2007) 1.16
Central pancreatectomy with pancreaticogastrostomy for benign pancreatic pathology. J Gastrointest Surg (2004) 1.15
Management of a pancreatic duct injury with an endoscopically placed stent. Surgery (2004) 1.13
Why do Black Americans have a higher risk of pancreatic cancer than White Americans? Epidemiology (2003) 1.13
Improved outcomes in postoperative and pancreatitis-related visceral pseudoaneurysms. J Gastrointest Surg (2007) 1.13
Preservation of replaced or accessory right hepatic artery during pancreaticoduodenectomy for adenocarcinoma: impact on margin status and survival. J Gastrointest Surg (2010) 1.12
N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma. J Gastrointest Surg (2012) 1.09
Impact of a computerized template on antibiotic prescribing for acute respiratory infections in children and adolescents. Clin Pediatr (Phila) (2010) 1.06
The who, what, and why of risk adjustment: a technology on the cusp of adoption. J Health Polit Policy Law (2005) 1.05
Peri-operative blood transfusion and operative time are quality indicators for pancreatoduodenectomy. HPB (Oxford) (2010) 1.04
Declining morbidity and mortality rates in the surgical management of pancreatic necrosis. J Gastrointest Surg (2007) 1.04
Solid pseudopapillary neoplasms of the pancreas: a multi-institutional study of 21 patients. J Surg Res (2009) 1.04
Deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1beta. Am J Physiol Heart Circ Physiol (2006) 1.04
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?: a 10-year contemporary experience with 1,173 patients at the Massachusetts General Hospital. J Gastrointest Surg (2013) 1.03
Comparing a diagnosis list with a survey method to identify children with chronic conditions in an urban health center. Ambul Pediatr (2002) 1.03
Does speed matter? The impact of operative time on outcome in laparoscopic surgery. Surg Endosc (2011) 1.03
Prevalence of basic information technology use by U.S. physicians. J Gen Intern Med (2006) 1.02